Sacubitril/valsartan significantly reduced cardiomyopathy risk in patients undergoing anthracycline chemotherapy, but further research is needed for broader applicability. Muvalaplin, an oral drug, ...
Skye Bioscience, Inc., a clinical-stage biotechnology company focused on metabolic health, announced its participation in the American Diabetes Association's 85th Scientific Sessions, scheduled for ...
WASHINGTON – The annual Society for Cardiovascular Angiography & Interventions (SCAI) meeting, SCAI Scientific Sessions 2025, will kick off on Thursday, May 1, 2025, with nearly 2,000 scientists, ...
Repatha VESALIUS-CV Trial Met Dual Primary Endpoints Demonstrating Reduction in CV Events in High-Risk Patients Who Have Never Had a Heart Attack or Stroke Real-World Evidence from the Repatha-CE ...
In 1954, James Garber Galbraith, M.D., established the Division of Neurosurgery within the Department of Surgery in the UAB Heersink School of Medicine, creating a culture of growth and compassionate ...
MannKind Corporation will present its inhaled insulin product, Afrezza, at the American Diabetes Association's 85th Scientific Sessions in Chicago from June 20-23, 2025. Dr. Michael J. Haller will ...
New findings presented at the American Heart Association’s Scientific Sessions are highlighting new efforts to prevent heart disease. Dr. Nishant Shah, an American Heart Association volunteer and ...
Content in second paragraph updated on 11/10/25. DALLAS, Nov. 10, 2025 — Despite major advances in care, nearly half of U.S. adults live with some form of cardiovascular disease or stroke, according ...
The 41st Annual J. Garber Galbraith, M.D., Scientific Session and Lecture was held on Nov. 8, in the Margaret Cameron Spain Auditorium, located within the Russell Wing Medical Educational Building at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results